{"id":"https://openalex.org/W3120736622","doi":"https://doi.org/10.1007/s12247-020-09526-1","title":"An Analysis of the Technical and Economic Influences of Particle Size Control of an Active Pharmaceutical Ingredient","display_name":"An Analysis of the Technical and Economic Influences of Particle Size Control of an Active Pharmaceutical Ingredient","publication_year":2021,"publication_date":"2021-01-06","ids":{"openalex":"https://openalex.org/W3120736622","doi":"https://doi.org/10.1007/s12247-020-09526-1","mag":"3120736622"},"language":"en","primary_location":{"id":"doi:10.1007/s12247-020-09526-1","doi":"https://doi.org/10.1007/s12247-020-09526-1","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12247-020-09526-1","pdf_url":null,"source":{"id":"https://openalex.org/S168111969","display_name":"Journal of Pharmaceutical Innovation","issn_l":"1872-5120","issn":["1872-5120","1939-8042"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Innovation","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"David Wilson","orcid":"https://orcid.org/0000-0001-6031-9070","observed_orcids":["https://orcid.org/0000-0001-6031-9070"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"David Wilson","raw_affiliation_strings":["Chemical Development, Pharmaceutical Technology & Development, AstraZeneca, Macclesfield, UK"],"raw_orcid":"https://orcid.org/0000-0001-6031-9070","affiliations":[{"raw_affiliation_string":"Chemical Development, Pharmaceutical Technology & Development, AstraZeneca, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044945563","display_name":"Alex Crampton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alex Crampton","raw_affiliation_strings":["Chemical Development, Pharmaceutical Technology & Development, AstraZeneca, Macclesfield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development, Pharmaceutical Technology & Development, AstraZeneca, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110196289","display_name":"R. A. L. Sullivan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rachel Sullivan","raw_affiliation_strings":["Chemical Development, Pharmaceutical Technology & Development, AstraZeneca, Macclesfield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development, Pharmaceutical Technology & Development, AstraZeneca, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021947100","display_name":"Alexander Liljeblad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Alexander Liljeblad","raw_affiliation_strings":["Product Development, Pharmaceutical Technology & Development, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Development, Pharmaceutical Technology & Development, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I105036370"],"apc_list":{"value":3280,"currency":"USD","value_usd":3280},"apc_paid":null,"fwci":0.0712,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.20540793,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"17","issue":"2","first_page":"501","last_page":"509"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.5580999851226807,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.5580999851226807,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10615","display_name":"Granular flow and fluidized beds","score":0.31690001487731934,"subfield":{"id":"https://openalex.org/subfields/2206","display_name":"Computational Mechanics"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12282","display_name":"Mineral Processing and Grinding","score":0.06920000165700912,"subfield":{"id":"https://openalex.org/subfields/2210","display_name":"Mechanical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/particle-size-control","display_name":"particle size control","score":0.996999979019165},{"id":"https://openalex.org/keywords/active-pharmaceutical-ingredients","display_name":"active pharmaceutical ingredients","score":0.9580000042915344},{"id":"https://openalex.org/keywords/wet-milling","display_name":"wet milling","score":0.9649999737739563},{"id":"https://openalex.org/keywords/dry-milling","display_name":"dry grinding","score":0.9129999876022339},{"id":"https://openalex.org/keywords/crystallization","display_name":"crystallization","score":0.9200000166893005},{"id":"https://openalex.org/keywords/production-costs","display_name":"production costs","score":0.7739999890327454},{"id":"https://openalex.org/keywords/regulatory-burden","display_name":"regulatory burden","score":0.9580000042915344},{"id":"https://openalex.org/keywords/supply-chain","display_name":"supply chain","score":0.7670000195503235},{"id":"https://openalex.org/keywords/oral-formulations","display_name":"oral dosage forms","score":0.5929999947547913},{"id":"https://openalex.org/keywords/process-scale-up","display_name":"process scale-up","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.7511109709739685},{"id":"https://openalex.org/C62064638","wikidata":"https://www.wikidata.org/wiki/Q553878","display_name":"Design for manufacturability","level":2,"score":0.6883059740066528},{"id":"https://openalex.org/C204320433","wikidata":"https://www.wikidata.org/wiki/Q7268772","display_name":"Quality by Design","level":3,"score":0.6832525134086609},{"id":"https://openalex.org/C178144697","wikidata":"https://www.wikidata.org/wiki/Q2111609","display_name":"Process analytical technology","level":3,"score":0.5612143278121948},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.5444149374961853},{"id":"https://openalex.org/C2778938233","wikidata":"https://www.wikidata.org/wiki/Q7180757","display_name":"Pharmaceutical manufacturing","level":2,"score":0.5024857521057129},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.4725073575973511},{"id":"https://openalex.org/C21880701","wikidata":"https://www.wikidata.org/wiki/Q2144042","display_name":"Process engineering","level":1,"score":0.4718860387802124},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.4559595584869385},{"id":"https://openalex.org/C2775924081","wikidata":"https://www.wikidata.org/wiki/Q55608371","display_name":"Control (management)","level":2,"score":0.4452120065689087},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.3986464738845825},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.3871489465236664},{"id":"https://openalex.org/C117671659","wikidata":"https://www.wikidata.org/wiki/Q11049265","display_name":"Manufacturing engineering","level":1,"score":0.3569469451904297},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3309018015861511},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.2606029510498047},{"id":"https://openalex.org/C21547014","wikidata":"https://www.wikidata.org/wiki/Q1423657","display_name":"Operations management","level":1,"score":0.2218000590801239},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.2073364555835724},{"id":"https://openalex.org/C174998907","wikidata":"https://www.wikidata.org/wiki/Q357662","display_name":"Work in process","level":2,"score":0.14272499084472656},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.13463684916496277},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.10254845023155212},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.08527559041976929},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/s12247-020-09526-1","doi":"https://doi.org/10.1007/s12247-020-09526-1","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12247-020-09526-1","pdf_url":null,"source":{"id":"https://openalex.org/S168111969","display_name":"Journal of Pharmaceutical Innovation","issn_l":"1872-5120","issn":["1872-5120","1939-8042"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Innovation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1967235049","https://openalex.org/W2003291502","https://openalex.org/W2005963788","https://openalex.org/W2016051420","https://openalex.org/W2025776529","https://openalex.org/W2049599102","https://openalex.org/W2066964643","https://openalex.org/W2076191691","https://openalex.org/W2081546158","https://openalex.org/W2139417013","https://openalex.org/W2317021237","https://openalex.org/W2887044811","https://openalex.org/W2894643708","https://openalex.org/W2900297862","https://openalex.org/W2938882950","https://openalex.org/W3005276216"],"related_works":["https://openalex.org/W2964434516","https://openalex.org/W2897177456","https://openalex.org/W3197356082","https://openalex.org/W4392169346","https://openalex.org/W283238374","https://openalex.org/W2129501367","https://openalex.org/W4307968707","https://openalex.org/W2068505863","https://openalex.org/W2473423845","https://openalex.org/W4414264354"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2021-01-18T00:00:00"}